268 related articles for article (PubMed ID: 21537547)
21. An improved mouse model that rapidly develops fibrosis in non-alcoholic steatohepatitis.
Matsumoto M; Hada N; Sakamaki Y; Uno A; Shiga T; Tanaka C; Ito T; Katsume A; Sudoh M
Int J Exp Pathol; 2013 Apr; 94(2):93-103. PubMed ID: 23305254
[TBL] [Abstract][Full Text] [Related]
22. Proteomic analysis of mice fed methionine and choline deficient diet reveals marker proteins associated with steatohepatitis.
Lee SJ; Kang JH; Iqbal W; Kwon OS
PLoS One; 2015; 10(4):e0120577. PubMed ID: 25849376
[TBL] [Abstract][Full Text] [Related]
23. Epigallocatechin gallate attenuated non-alcoholic steatohepatitis induced by methionine- and choline-deficient diet.
Ding Y; Sun X; Chen Y; Deng Y; Qian K
Eur J Pharmacol; 2015 Aug; 761():405-12. PubMed ID: 25967348
[TBL] [Abstract][Full Text] [Related]
24. Modulatory role of Co-enzyme Q10 on methionine and choline deficient diet-induced non-alcoholic steatohepatitis (NASH) in albino rats.
Saleh DO; Ahmed RF; Amin MM
Appl Physiol Nutr Metab; 2017 Mar; 42(3):243-249. PubMed ID: 28177750
[TBL] [Abstract][Full Text] [Related]
25. Activation of peroxisome proliferator-activated receptor alpha by dietary fish oil attenuates steatosis, but does not prevent experimental steatohepatitis because of hepatic lipoperoxide accumulation.
Larter CZ; Yeh MM; Cheng J; Williams J; Brown S; dela Pena A; Bell-Anderson KS; Farrell GC
J Gastroenterol Hepatol; 2008 Feb; 23(2):267-75. PubMed ID: 17868330
[TBL] [Abstract][Full Text] [Related]
26. Differential hepatotoxicity of dietary and DNL-derived palmitate in the methionine-choline-deficient model of steatohepatitis.
Pierce AA; Pickens MK; Siao K; Grenert JP; Maher JJ
BMC Gastroenterol; 2015 Jun; 15():72. PubMed ID: 26103964
[TBL] [Abstract][Full Text] [Related]
27. p53/p66Shc-mediated signaling contributes to the progression of non-alcoholic steatohepatitis in humans and mice.
Tomita K; Teratani T; Suzuki T; Oshikawa T; Yokoyama H; Shimamura K; Nishiyama K; Mataki N; Irie R; Minamino T; Okada Y; Kurihara C; Ebinuma H; Saito H; Shimizu I; Yoshida Y; Hokari R; Sugiyama K; Hatsuse K; Yamamoto J; Kanai T; Miura S; Hibi T
J Hepatol; 2012 Oct; 57(4):837-43. PubMed ID: 22641095
[TBL] [Abstract][Full Text] [Related]
28. Tauroursodeoxycholic acid attenuates progression of steatohepatitis in mice fed a methionine-choline-deficient diet.
Cho EJ; Yoon JH; Kwak MS; Jang ES; Lee JH; Yu SJ; Kim YJ; Kim CY; Lee HS
Dig Dis Sci; 2014 Jul; 59(7):1461-74. PubMed ID: 24865256
[TBL] [Abstract][Full Text] [Related]
29. Monocyte chemoattractant protein-1 deficiency does not affect steatosis or inflammation in livers of mice fed a methionine-choline-deficient diet.
Kassel KM; Guo GL; Tawfik O; Luyendyk JP
Lab Invest; 2010 Dec; 90(12):1794-804. PubMed ID: 20697377
[TBL] [Abstract][Full Text] [Related]
30. Metabolic impact of partial hepatectomy in the non-alcoholic steatohepatitis animal model of methionine-choline deficient diet.
Carril E; Valdecantos MP; Lanzón B; Angulo S; Valverde ÁM; Godzien J; Rupérez FJ
J Pharm Biomed Anal; 2020 Jan; 178():112958. PubMed ID: 31718984
[TBL] [Abstract][Full Text] [Related]
31. Dynamic alterations in the gut microbiota and metabolome during the development of methionine-choline-deficient diet-induced nonalcoholic steatohepatitis.
Ye JZ; Li YT; Wu WR; Shi D; Fang DQ; Yang LY; Bian XY; Wu JJ; Wang Q; Jiang XW; Peng CG; Ye WC; Xia PC; Li LJ
World J Gastroenterol; 2018 Jun; 24(23):2468-2481. PubMed ID: 29930468
[TBL] [Abstract][Full Text] [Related]
32. The treatment with antibody of TNF-alpha reduces the inflammation, necrosis and fibrosis in the non-alcoholic steatohepatitis induced by methionine- and choline-deficient diet.
Koca SS; Bahcecioglu IH; Poyrazoglu OK; Ozercan IH; Sahin K; Ustundag B
Inflammation; 2008 Apr; 31(2):91-8. PubMed ID: 18066656
[TBL] [Abstract][Full Text] [Related]
33. Treatment with geraniol ameliorates methionine-choline-deficient diet-induced non-alcoholic steatohepatitis in rats.
Chen J; Fan X; Zhou L; Gao X
J Gastroenterol Hepatol; 2016 Jul; 31(7):1357-65. PubMed ID: 26695085
[TBL] [Abstract][Full Text] [Related]
34. Attenuation of steatohepatitis, fibrosis, and carcinogenesis in mice fed a methionine-choline deficient diet by CCAAT/enhancer-binding protein homologous protein deficiency.
Toriguchi K; Hatano E; Tanabe K; Takemoto K; Nakamura K; Koyama Y; Seo S; Taura K; Uemoto S
J Gastroenterol Hepatol; 2014 May; 29(5):1109-18. PubMed ID: 24329600
[TBL] [Abstract][Full Text] [Related]
35. Alpha-syntrophin null mice are protected from non-alcoholic steatohepatitis in the methionine-choline-deficient diet model but not the atherogenic diet model.
Rein-Fischboeck L; Haberl EM; Pohl R; Schmid V; Feder S; Krautbauer S; Liebisch G; Buechler C
Biochim Biophys Acta Mol Cell Biol Lipids; 2018 May; 1863(5):526-537. PubMed ID: 29474931
[TBL] [Abstract][Full Text] [Related]
36. Toll-like receptor-2 deficiency enhances non-alcoholic steatohepatitis.
Rivera CA; Gaskin L; Allman M; Pang J; Brady K; Adegboyega P; Pruitt K
BMC Gastroenterol; 2010 May; 10():52. PubMed ID: 20509914
[TBL] [Abstract][Full Text] [Related]
37. Increased susceptibility to experimental steatohepatitis induced by methionine-choline deficiency in HBs-Tg mice.
Fu MM; Sun R; Tian ZG; Wei HM
Hepatobiliary Pancreat Dis Int; 2010 Oct; 9(5):513-9. PubMed ID: 20943461
[TBL] [Abstract][Full Text] [Related]
38. β
Drescher HK; Schippers A; Clahsen T; Sahin H; Noels H; Hornef M; Wagner N; Trautwein C; Streetz KL; Kroy DC
J Hepatol; 2017 Jun; 66(6):1251-1264. PubMed ID: 28192190
[TBL] [Abstract][Full Text] [Related]
39. Nifedipine prevents hepatic fibrosis in a non-alcoholic steatohepatitis model induced by an L-methionine-and choline-deficient diet.
Nakagami H; Shimamura M; Miyake T; Shimosato T; Minobe N; Moritani T; Kiomy Osako M; Nakagami F; Koriyama H; Kyutoku M; Shimizu H; Katsuya T; Morishita R
Mol Med Rep; 2012 Jan; 5(1):37-40. PubMed ID: 21946918
[TBL] [Abstract][Full Text] [Related]
40. Hepatic microvascular dysfunction during evolution of dietary steatohepatitis in mice.
McCuskey RS; Ito Y; Robertson GR; McCuskey MK; Perry M; Farrell GC
Hepatology; 2004 Aug; 40(2):386-93. PubMed ID: 15368443
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
